STEREO-SEQ
LIVE

Serial Number

97980389

Owner

MGI Holdings Co., Limited

Attorney

Charles Ho

First Use Date

Oct 11, 2021

Filing Date

Jan 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

STEREO-SEQ Trademark

Serial Number: 97980389 • Registration: 7877543

STEREO-SEQ is a trademark filed by MGI Holdings Co., Limited on January 17, 2023. The trademark is classified under Class 1 (Chemicals). The application is currently registered and active.

Owner Contact Info

MGI Holdings Co., Limited (5 trademarks)

8F, Building 11, Beishan Industrial Zone
Yantian District, Shenzhen, Guangdong , CN

Entity Type: 99

BGI SHENZHEN GROUP HOLDINGS CO., LIMITED (9 trademarks)

8F, Building 11, Beishan Industrial

Entity Type: 99

Trademark Details

Filing Date

January 17, 2023

Registration Date

August 5, 2025

First Use Anywhere

October 11, 2021

First Use in Commerce

October 11, 2021

Published for Opposition

November 21, 2023

Goods & Services

Enzyme preparations for industrial purposes; Protein in raw material form for scientific and medical research; Biochemical catalysts; Enzymes for industrial purposes; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic preparations, other than for medical or veterinary purposes; Chemical reagents, other than for medical or veterinary purpose; Biological preparations, other than for medical or veterinary purposes, namely, for use in industry and science; Cultures of microorganisms, other than for medical and veterinary use; Bacterial preparations, other than for medical and veterinary use; Biochemical preparations for scientific purposes; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 5, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jul 14, 2025 DP1B
DIVISIONAL PROCESSING COMPLETE
Jul 14, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 7, 2025 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 6, 2024 ASGN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 25, 2024 AITU
NOTICE OF ALLOWANCE CANCELLED
Mar 11, 2024 IUCN
DIVISIONAL REQUEST RECEIVED
Mar 11, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Mar 11, 2024 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2023 CNSA
ASSIGNED TO EXAMINER
Oct 16, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2023 NWOS
NEW APPLICATION ENTERED
Jan 20, 2023 NWAP